Cohen K - Search Results

1

Accuracy of measures for antiretroviral adherence in people living with HIV.

Smith R, Villanueva G, Probyn K, Sguassero Y, Ford N, Orrell C, Cohen K, Chaplin M, Leeflang MM, Hine P. Smith R, et al. Among authors: cohen k. Cochrane Database Syst Rev. 2022 Jul 25;7(7):CD013080. doi: 10.1002/14651858.CD013080.pub2. Cochrane Database Syst Rev. 2022. PMID: 35871531 Free PMC article. Review.

2

Antiretroviral therapy in a community clinic--early lessons from a pilot project.

Bekker LG, Orrell C, Reader L, Matoti K, Cohen K, Martell R, Abdullah F, Wood R. Bekker LG, et al. Among authors: cohen k. S Afr Med J. 2003 Jun;93(6):458-62. S Afr Med J. 2003. PMID: 12916388

3

Antiretroviral therapy and early mortality in South Africa.

Boulle A, Bock P, Osler M, Cohen K, Channing L, Hilderbrand K, Mothibi E, Zweigenthal V, Slingers N, Cloete K, Abdullah F. Boulle A, et al. Among authors: cohen k. Bull World Health Organ. 2008 Sep;86(9):678-87. doi: 10.2471/blt.07.045294. Bull World Health Organ. 2008. PMID: 18797643 Free PMC article.

4

Therapeutic drug monitoring of antiretrovirals for people with HIV.

Kredo T, Van der Walt JS, Siegfried N, Cohen K. Kredo T, et al. Among authors: cohen k. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007268. doi: 10.1002/14651858.CD007268.pub2. Cochrane Database Syst Rev. 2009. PMID: 19588422 Review.

5

Management of individuals requiring antiretroviral therapy and TB treatment.

Cohen K, Meintjes G. Cohen K, et al. Curr Opin HIV AIDS. 2010 Jan;5(1):61-9. doi: 10.1097/COH.0b013e3283339309. Curr Opin HIV AIDS. 2010. PMID: 20046149 Free PMC article. Review.

6

Efavirenz and rifampicin in the South African context: is there a need to dose-increase efavirenz with concurrent rifampicin therapy?

Orrell C, Cohen K, Conradie F, Zeinecker J, Ive P, Sanne I, Wood R. Orrell C, et al. Among authors: cohen k. Antivir Ther. 2011;16(4):527-34. doi: 10.3851/IMP1780. Antivir Ther. 2011. PMID: 21685540 Free PMC article. Clinical Trial.

7

A Randomized Controlled Trial of Real-Time Electronic Adherence Monitoring With Text Message Dosing Reminders in People Starting First-Line Antiretroviral Therapy.

Orrell C, Cohen K, Mauff K, Bangsberg DR, Maartens G, Wood R. Orrell C, et al. Among authors: cohen k. J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):495-502. doi: 10.1097/QAI.0000000000000770. J Acquir Immune Defic Syndr. 2015. PMID: 26218411 Clinical Trial.

8

Effect of mid-dose efavirenz concentrations and CYP2B6 genotype on viral suppression in patients on first-line antiretroviral therapy.

Orrell C, Bienczak A, Cohen K, Bangsberg D, Wood R, Maartens G, Denti P. Orrell C, et al. Among authors: cohen k. Int J Antimicrob Agents. 2016 Jun;47(6):466-72. doi: 10.1016/j.ijantimicag.2016.03.017. Epub 2016 May 4. Int J Antimicrob Agents. 2016. PMID: 27211824

9

Random lopinavir concentrations predict resistance on lopinavir-based antiretroviral therapy.

Court R, Gordon M, Cohen K, Stewart A, Gosnell B, Wiesner L, Maartens G. Court R, et al. Among authors: cohen k. Int J Antimicrob Agents. 2016 Aug;48(2):158-62. doi: 10.1016/j.ijantimicag.2016.04.030. Epub 2016 Jun 9. Int J Antimicrob Agents. 2016. PMID: 27345268 Free PMC article.

10

Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.

Mouton JP, Cohen K, Maartens G. Mouton JP, et al. Among authors: cohen k. Expert Rev Clin Pharmacol. 2016 Nov;9(11):1493-1503. doi: 10.1080/17512433.2016.1221760. Epub 2016 Aug 22. Expert Rev Clin Pharmacol. 2016. PMID: 27498720 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

993 results

Search Page